Working… Menu

Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02723435
Recruitment Status : Withdrawn (Logistical and administrative issues)
First Posted : March 30, 2016
Last Update Posted : May 4, 2018
Information provided by (Responsible Party):
David Iberri, Stanford University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : April 2018
Actual Study Completion Date : April 2018